# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5275806 | 14 | IC50 | = | 90 | nM | ALA5226566 | 7.05 | nM | Homo sapiens | ||
2. | ALA5280582 | 13 | IC50 | = | 4 | nM | ALA5226566 | 8.40 | nM | Homo sapiens | ||
3. | ALA5267102 | 12 | IC50 | = | 1 | nM | ALA5226566 | 9.00 | nM | Homo sapiens | ||
4. | ALA5283631 | 11 | IC50 | = | 1 | nM | ALA5226566 | 9.00 | nM | Homo sapiens | ||
5. | Fenretinide | 25 (4-HPR) | IC50 | = | 100 | nM | ALA5226566 | 7.00 | nM | Homo sapiens | ||
6. | ALA5275998 | 1; GT11 | Ki | = | 22 | nM | ALA5226563 | 7.66 | nM | Homo sapiens | ||
7. | ALA5268107 | 3 | IC50 | = | 155 | nM | ALA5226562 | 6.81 | nM | Homo sapiens | ||
8. | ALA5275998 | 1; GT11 | IC50 | = | 52 | nM | ALA5226562 | 7.28 | nM | Homo sapiens | ||
9. | SKI II | 12 | Ki | = | 0.3 | uM | ALA5226556 | 6.52 | nM | Homo sapiens | ||
10. | LCL521 dihydrochloride | LCL521; 1,3-di-DMG-B13 2HCl | INH | 0 | ALA4310700 | Active | % | Homo sapiens | ||||
11. | RBM2-1B | RBM2-1B | INH | 0 | ALA2026164 | Dose-dependent effect | % | Homo sapiens | ||||
12. | RBM2-1B | RBM2-1B | INH | 0 | ALA2026163 | Dose-dependent effect | % | Homo sapiens | ||||
13. | ALA2024682 | RBM2-1D | INH | = | 50 | % | ALA2026241 | % | Homo sapiens | |||
14. | ALA2024681 | RBM2-1C | INH | = | 50 | % | ALA2026241 | % | Homo sapiens | |||
15. | ALA2024682 | RBM2-1D | INH | = | 50 | % | ALA2026240 | % | Homo sapiens | |||
16. | ALA2024681 | RBM2-1C | INH | = | 50 | % | ALA2026240 | % | Homo sapiens | |||
17. | RBM2-1B | RBM2-1B | IC50 | = | 18.8 | uM | ALA2026164 | 4.73 | nM | Homo sapiens | ||
18. | RBM2-1B | RBM2-1B | IC50 | = | 18.1 | uM | ALA2026163 | 4.74 | nM | Homo sapiens | ||
19. | ALA3765391 | 44 | Drug metabolism | 0 | ALA3767374 | metabolite_detected | Homo sapiens | |||||
20. | Fenretinide | 25 (4-HPR) | Drug metabolism | 0 | ALA3767373 | metabolite_detected | Homo sapiens |